(29 days)
No
The description focuses on basic electrical stimulation principles and pre-set or user-defined programs, with no mention of AI or ML capabilities.
Yes.
The device is specifically designed for therapeutic purposes, including temporary pain relief (TENS) and stimulating healthy muscles to improve performance (EMS), both of which are aimed at improving or maintaining physiological function or alleviating symptomatic conditions.
No
The device is described as an "Electrical Stimulator" for temporary pain relief (TENS) and muscle stimulation (EMS), not for diagnosing medical conditions.
No
The device description explicitly states it "falls into the electro stimulation device category" and describes hardware components like "two independent stimulation channels and four adhesive electrodes." This indicates it is a physical device that delivers electrical stimulation, not solely software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body, such as blood, urine, or tissue, to provide information for diagnosis, monitoring, or screening.
- Device Function: The HIVOX OTC Electrical Stimulator (EM49-1 and EM49-2) is an electrostimulation device that applies electrical impulses to the body through electrodes placed on the skin. It is used for pain relief (TENS) and muscle stimulation (EMS).
- Lack of Specimen Analysis: The device does not involve the collection or analysis of any biological specimens from the body. It directly interacts with the body's nerves and muscles.
- Intended Use: The intended use clearly describes the application of electrical stimulation for pain relief and muscle performance, not for diagnostic testing using biological samples.
Therefore, the HIVOX OTC Electrical Stimulator falls under the category of electrostimulation devices, not In Vitro Diagnostic devices.
N/A
Intended Use / Indications for Use
HIVOX OTC Electrical Stimulator, EM49-1 -
TENS: The device is designed to be used for temporary relief of pain associated with sore and aching muscles in the shoulder, waist, back, neck, upper extremities (arm), lower extremities (leg), abdomen and bottom due to strain from exercise or normal household work activities.
HIVOX OTC Electrical Stimulator, EM49-2 -
TENS: The device is designed to be used for temporary relief of pain associated with sore and aching muscles in the shoulder, waist, back, neck, upper extremities (arm), lower extremities (leg), abdomen and bottom due to strain from exercise or normal household work activities.
EMS: The device is designed to be used for stimulate healthy muscles in order to improve and facilitate muscle performance.
Product codes (comma separated list FDA assigned to the subject device)
NUH, NGX
Device Description
HIVOX OTC Electrical Stimulator – EM49-1 and EM49-2, falls into the electro stimulation device category.
EM49-1 provides one basic function, TENS, whereas EM49-2 provides two basic functions, TENS/EMS:
-
Electrical stimulation of nerve tracts (TENS)
-
Electrical stimulation of muscle tissue (EMS)
The two models also feature two independent stimulation channels and four adhesive electrodes which FDA cleared k number is K132588. For TENS, EM49-1 and EM49-2 are designed to be used for temporary relief of pain associated with sore and aching muscles in the shoulder, waist, back, neck, upper extremities (arm), lower extremities (leg), abdomen and bottom due to strain from exercise or normal household work activities; for EMS, EM49-2 is designed to be used for stimulating healthy muscles in order to improve and facilitate muscle performance. For these purposes, the user can either choose from pre-set programs or specify their own to suit the user's individual needs.
The principle of electro stimulation units is based on the imitation of impulses in our bodies that are transferred to nerve and muscle fibers with electrodes via our skin. The electrodes can be applied to many parts of the body. In certain applications the user will merely notice a slight tingling or vibrating sensation. For EM49-1, the electrical impulses that are sent into the tissue influence the transmission of stimulation into nerves and nerve centers in the application area: for EM49-2, the electrical impulses that are sent into the tissue influence the transmission of stimulation into nerves, nerve centers and muscle groups in the application area.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
shoulder, waist, back, neck, upper extremities (arm), lower extremities (leg), abdomen and bottom
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Over-The-Counter Use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
A series of safety and performance tests were conducted on the subject device, HIVOX OTC Electrical Stimulator (EM49-1, EM49-2).
- . Shelf Life
- Biocompatibility .
- Software Validation
- . Electromagnetic compatibility and electrical safety
- Function test
- . Usability
All the test results demonstrate HIVOX OTC Electrical Stimulator (EM49-1, EM49-2) meets the requirements of its pre-defined acceptance criteria and intended use, and is substantially equivalent to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.5890 Transcutaneous electrical nerve stimulator for pain relief.
(a)
Identification. A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services seal on the left and the FDA acronym along with the full name of the agency on the right. The FDA part of the logo is in blue, with the acronym in a square and the full name written out as "U.S. Food & Drug Administration".
March 15, 2019
Hivox Biotek Inc. Marx Lee Regulatory Affairs 5F., No. 123, Xingde Rd. Sanchong Dist. New Taipei City, TW 24158
Re: K190347
Trade/Device Name: HIVOX OTC Electrical Stimulator Regulation Number: 21 CFR 882.5890 Regulation Name: Transcutaneous Electrical Nerve Stimulator For Pain Relief Regulatory Class: Class II Product Code: NUH, NGX Dated: February 13, 2019 Received: February 14, 2019
Dear Marx Lee:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Actinclude requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Pamela D. Scott -S
for Carlos L. Peña. PhD. MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K190347
Device Name
HIVOX OTC Electrical Stimulator (EM49-1, EM49-2)
Indications for Use (Describe)
HIVOX OTC Electrical Stimulator, EM49-1 -
TENS: The device is designed to be used for temporary relief of pain associated with sore and aching muscles in the shoulder, waist, back, neck, upper extremities (arm), lower extremities (leg), abdomen and bottom due to strain from exercise or normal household work activities.
HIVOX OTC Electrical Stimulator, EM49-2 -
TENS: The device is designed to be used for temporary relief of pain associated with sore and aching muscles in the shoulder, waist, back, neck, upper extremities (arm), lower extremities (leg), abdomen and bottom due to strain from exercise or normal household work activities.
EMS: The device is designed to be used for stimulate healthy muscles in order to improve and facilitate muscle performance.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
|X | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
HIVOX OTC Electrical Stimulator (EM49-1, EM49-2)
Section 6- 510(k) Summary
510(k) SUMMARY
| 6.1 | Type of Submission: | Special |
|---|---|---|
| 6.2 | Date of Summary: | February 13, 2019 |
| 6.3 | Submitter: | HIVOX BIOTEK INC. |
| Address: | 5F., No. 123, Xingde Rd., Sanchong Dist., New | |
| Taipei City 24158, Taiwan, R.O.C. | ||
| Phone: | +886-2-8511-2668 | |
| Fax: | +886-2-8511-2669 | |
| Contact: | Marx Lee | |
| (marx.lee@hivox-biotek.com) |
6.4 Identification of the Device:
| Proprietary/Trade name: | HIVOX OTC Electrical Stimulator |
|---|---|
| Model Number: | EM49-1, EM49-2 |
| Classification Product Code: | NUH |
| Subsequent Product Code: | NGX |
| Regulation Number: | 1) 882.5890 |
- 890.5850 |
| Regulation Description: | 1) Transcutaneous electrical nerve
stimulator for pain relief - Powered muscle stimulator |
| Review Panel: | 1) Neurology - Physical Medicine |
| Device Class: | II |
6.5 Identification of the Predicate Device:
| Predicate Device Name : | HIVOX OTC Electrical Stimulator |
|---|---|
| Model Number: | SEM44, SEM44-1 |
| Manufacturer: | HIVOX BIOTEK INC. |
4
HIVOX OTC Electrical Stimulator (EM49-1, EM49-2)
| Classification Product Code: | NUH |
|---|---|
| Subsequent Product Code: | NGX |
| Regulation number: | 1) 882.5890 |
| 2) 890.5850 | |
| Device Class: | II |
| 510(k) Number: | K171803 |
Intended Use/Indications for Use of the Device 6.6
HIVOX OTC Electrical Stimulator, EM49-1 -
TENS: The device is designed to be used for temporary relief of pain associated with sore and aching muscles in the shoulder, waist, back, neck, upper extremities (arm), lower extremities (leg), abdomen and bottom due to strain from exercise or normal household work activities.
HIVOX OTC Electrical Stimulator, EM49-2 -
TENS: The device is designed to be used for temporary relief of pain associated with sore and aching muscles in the shoulder, waist, back, neck, upper extremities (arm), lower extremities (leg), abdomen and bottom due to strain from exercise or normal household work activities.
EMS: The device is designed to be used for stimulate healthy muscles in order to improve and facilitate muscle performance.
6.7 De vice Descrintion
HIVOX OTC Electrical Stimulator – EM49-1 and EM49-2, falls into the electro stimulation device category.
EM49-1 provides one basic function, TENS, whereas EM49-2 provides two basic functions, TENS/EMS:
-
Electrical stimulation of nerve tracts (TENS)
-
Electrical stimulation of muscle tissue (EMS)
5
The two models also feature two independent stimulation channels and four adhesive electrodes which FDA cleared k number is K132588. For TENS, EM49-1 and EM49-2 are designed to be used for temporary relief of pain associated with sore and aching muscles in the shoulder, waist, back, neck, upper extremities (arm), lower extremities (leg), abdomen and bottom due to strain from exercise or normal household work activities; for EMS, EM49-2 is designed to be used for stimulating healthy muscles in order to improve and facilitate muscle performance. For these purposes, the user can either choose from pre-set programs or specify their own to suit the user's individual needs.
The principle of electro stimulation units is based on the imitation of impulses in our bodies that are transferred to nerve and muscle fibers with electrodes via our skin. The electrodes can be applied to many parts of the body. In certain applications the user will merely notice a slight tingling or vibrating sensation. For EM49-1, the electrical impulses that are sent into the tissue influence the transmission of stimulation into nerves and nerve centers in the application area: for EM49-2, the electrical impulses that are sent into the tissue influence the transmission of stimulation into nerves, nerve centers and muscle groups in the application area.
6.8 Non-clinical Testing
A series of safety and performance tests were conducted on the subject device, HIVOX OTC Electrical Stimulator (EM49-1, EM49-2).
- . Shelf Life
- Biocompatibilit y .
- Software Validation
- . Electromagnetic compatibility and electrical safety
- Function test
- . Usability
All the test results demonstrate HIVOX OTC Electrical Stimulator (EM49-1, EM49-2) meets the requirements of its pre-defined acceptance criteria and intended use, and is substantially equivalent to the predicate device.
6
Section 6- 510(k) Summary
HIVOX OTC Electrical Stimulator (EM49-1, EM49-2)
6.9 Clinical Testing
No clinical test data was used to support the decision of substantial equivalence.
Comparison of Differences and Substantial Equivalence Determination 6.10
The HIVOX OTC Electrical Stimulator (EM49-1, EM49-2) submitted in this 510(k) file is substantially equivalent in intended use, design, technology/principles of operation, materials and performance to the cleared HIVOX OTC Electrical Stimulator (SEM44, SEM44-1) (K171803). Differences between the devices cited in the following do not raise any new issue of substantial equivalence.
| Subject device | Predicate device | Substantial equivalence determination |
|---|---|---|
| Model: | ||
| EM49-1/EM49-2 | Model: | |
| SEM44/SEM44-1 | Different in product model. | |
| However, it does not affect the intended use or alter the | ||
| fundamental scientific technology of subject device. | ||
| Negative | ||
| display type LCD | Positive | |
| display type LCD | Changed for the sake of product segmentation. | |
| However, it does not affect the intended use or alter the | ||
| fundamental scientific technology of subject device. | ||
| Arrangement of buttons | Changed for the sake of product segmentation. | |
| However, it does not affect the intended use or alter the | ||
| fundamental scientific technology of subject device. | ||
| Type of connection cable plug | Changed for the sake of product segmentation. | |
| However, it does not affect the intended use or alter the | ||
| fundamental scientific technology of subject device. | ||
| PCB layout | Changed due to the use of different type of LCD and | |
| arrangement of buttons. | ||
| However, it does not affect the intended use or alter the | ||
| fundamental scientific technology of subject device. | ||
| Weight | Difference because of different design of product appearance. | |
| However, it does not affect the intended use or alter the | ||
| fundamental scientific technology of subject device. |
7
HIVOX OTC Electrical Stimulator (EM49-1, EM49-2)
6.11 Discussion
The HIVOX OTC Electrical Stimulator (EM49-1, EM49-2) has been compared with "HIVOX OTC Electrical Stimulator (SEM44, SEM44-1)". The subject device has same intended use, principle of operation and technological characteristics as the predicate device. We have completed the design control process and the validation tests to confirm the safety and performance of subject device. Although there are some specifications that are different between two devices, the test results complied with the test requests, and this demonstrates that the differences between these parameters would not impact the safety and effectiveness of the subject device. Therefore, the difference between the subject device and the predicate device did not raise any problem of substantial equivalence. The subject device is substantially equivalent to the predicate device in intended use, safety and performance claims.
6.12 Conclusion
After analyzing non-clinical laboratory studies and related testing data, it can be concluded that the HIVOX OTC Electrical Stimulator (EM49-1, EM49-2) is substantially equivalent to the predicate device.
8
7/6